Xcout Intel
Naveris, Inc.
Naveris, Inc. is a biotechnology research and cancer detection company located in Waltham, Massachusetts. It specializes in developing advanced molecular diagnostic blood tests for HPV-associated cancers.
Subscribe to see Naveris, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Naveris, Inc. at a glance
Naveris, Inc. is a diagnostics company headquartered in United States. Its most recent funding round raised $17.5M in June 2024. Xcout tracks 1 named person at Naveris, Inc., including John Hanna (President and Chief Executive Officer). Xcout recorded 1 job posting from Naveris, Inc. in the last 90 days.
Naveris, Inc. leadership
- John HannaPresident and Chief Executive Officer
Naveris, Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $17.5M | — | |
| Series A | $19M | 1 named | |
| SEC Form D filing | $15.4M | — | |
| SEC Form D filing | $650,000 | — | |
| Series A | $3M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Naveris, Inc.
Xcout recorded 1 job posting from Naveris, Inc. in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Naveris, Inc.'s hiring signals →
Recent Naveris, Inc. news
Investors
Naveris, Inc. competitors
A few of Naveris, Inc.'s closest competitors — see the full list of competitors and alternatives →
Mercy BioAnalytics, Inc. is a privately held biotechnology company founded in 2018 and headquartered in Waltham, Massachusetts. The company is dedicated to developing early diagnostics and detection technologies.
Nucleix is a liquid biopsy company headquartered in Rehovot, Israel. It aims to revolutionize cancer treatment through earlier disease detection, focusing on interventions that can bring the greatest impact.
Precede Biosciences is a biotechnology company developing blood-based liquid-biopsy technologies for molecular profiling of cancer. Its tests are intended to support oncology research, precision treatment decisions, and pharmaceutical drug-development programs.
Resolution Bioscience is a precision medicine company specializing in cancer diagnostics, DNA sequencing, and liquid biopsy, located in Bellevue, Washington.
Nexosome Oncology Holdings, Inc. develops blood tests for early-stage cancer detection using patented extracellular vesicle proteomics and AI/ML biomarker discovery. The company serves patients and healthcare partners by providing highly accurate diagnostic tools.
Exosome Diagnostics, Inc. is a molecular diagnostics company located in Massachusetts, United States. The company specializes in developing biofluid-based liquid biopsy tests, such as the ExoDx Prostate test, for use in personalized medicine and oncology.
Get Naveris, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Naveris, Inc. in Xcout Intel
- 1 named person with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- 1 corporate event with sources — deals, leadership changes, layoffs
- The full competitor set, tracking, exports and API access